0001209191-21-024664.txt : 20210402
0001209191-21-024664.hdr.sgml : 20210402
20210402170029
ACCESSION NUMBER: 0001209191-21-024664
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210401
FILED AS OF DATE: 20210402
DATE AS OF CHANGE: 20210402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weiser Jorg
CENTRAL INDEX KEY: 0001797782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 21802683
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-01
0
0001490978
Schrodinger, Inc.
SDGR
0001797782
Weiser Jorg
C/O SCHRODINGER, INC.,
120 WEST 45TH STREET, 17TH FLOOR
NEW YORK
NY
10036
0
1
0
0
EVP & Managing Director
Common Stock
2021-04-01
4
M
0
418
4.34
A
117470
D
Common Stock
2021-04-01
4
S
0
418
78.34
D
117052
D
Common Stock
17390
I
BY ANTERIO CONSULT AND RESEARCH GMBH
Stock Option (right to buy)
4.34
2021-04-01
4
M
0
418
0.00
D
2028-11-29
Common Stock
418
9196
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2020
The shares are beneficially owned by Anterio Consult & Research GmbH ("Anterio"). Dr. Weiser is a shareholder and former managing director of Anterio and disclaims beneficial ownership of the shares held by Anterio, except to the extent of his pecuniary interest therein, if any.
This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.
/s/ Donald Shum, as attorney-in-fact for Jorg Weiser
2021-04-02